A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.
PHASE3CompletedINTERVENTIONAL
Enrollment
402
Participants
Timeline
Start Date
March 31, 2005
Study Completion Date
November 30, 2006
Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG
methylphenidate hydrochloride
All Listed Sponsors
lead
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
NCT00246220 - A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder. | Biotech Hunter | Biotech Hunter